The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
The grants are expected to be received over the next three years, commencing March 2022
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
Subscribe To Our Newsletter & Stay Updated
